NVDA vs OST

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.

OST exhibits severe financial distress, anchored by a weak Piotroski F-Score of 3/9 and a critical liquidity crisis. The company's current ratio of 0.46 and quick ratio of 0.25 indicate an inability to meet short-term obligations, while a Debt/Equity ratio of 2.81 signals over-leverage. A catastrophic 1-year price decline of 97.9% from a 52-week high of $235.00 suggests a total loss of investor confidence and potential structural failure. With an ROE of -109.41% and negative profit margins, the business model is currently unsustainable.